Compare CPRX & POWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CPRX | POWI |
|---|---|---|
| Founded | 2002 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 4.1B |
| IPO Year | 2006 | 1997 |
| Metric | CPRX | POWI |
|---|---|---|
| Price | $31.17 | $73.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $35.00 | ★ $60.00 |
| AVG Volume (30 Days) | ★ 2.3M | 1.0M |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.23% |
| EPS Growth | ★ 28.24 | N/A |
| EPS | ★ 1.68 | 0.06 |
| Revenue | $119,072,803.00 | ★ $443,504,000.00 |
| Revenue This Year | $9.20 | $8.12 |
| Revenue Next Year | $10.51 | $16.54 |
| P/E Ratio | ★ $18.54 | $185.26 |
| Revenue Growth | ★ 16.39 | 5.86 |
| 52 Week Low | $19.05 | $30.86 |
| 52 Week High | $32.56 | $78.95 |
| Indicator | CPRX | POWI |
|---|---|---|
| Relative Strength Index (RSI) | 73.25 | 62.96 |
| Support Level | $22.41 | $43.57 |
| Resistance Level | $32.56 | $76.22 |
| Average True Range (ATR) | 1.30 | 4.78 |
| MACD | 0.30 | -0.02 |
| Stochastic Oscillator | 80.10 | 54.59 |
Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.
Power Integrations Inc designs, develops, and markets analog and mixed-signal integrated circuits (ICs) and other electronic components and circuitry used in high-voltage power conversion. Products are used in power converters that convert electricity from a high-voltage source to the type of power required for a specified downstream use. Products are used in electronic products including mobile phones, computing and networking equipment, appliances, electronic utility meters, battery-powered tools, industrial controls, home automation, or Internet of Things applications such as networked thermostats, power strips, and security devices. Geographically, the company generates maximum revenue from China and Hong Kong.